ALNY Forecast and Technical Stock Analysis
Buy candidate since 2019-08-06 Gain 10.51%
Alnylam Pharmaceuticals gained 1.87% in the last trading day ( Monday, 19th Aug 2019 ), rising from $80.69 to $82.20 , and has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the day the stock fluctuated 2.54% from a day low at $80.46 to a day high of $82.50. The price has risen in 6 of the last 10 days and is up by 15.11% over the past 2 weeks. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 233 059 more shares were traded than the day before. In total, 714 332 shares bought and sold for approximately $58.72 million.
- 30 day high of the ALNY stock price was $84.48 and low was $69.11.
- 90 day high was $84.48 and low was $65.89.
- 52 week high for Alnylam Pharmaceuticals - $124.22 and low - $60.27.
Alnylam Pharmaceuticals lies in the upper part of a wide and strong rising trend in the short term, and this will normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $84.34 will firstly indicate a stronger raising rate. Given the current short-term trend, the stock is expected to rise 17.18% during the next 3 months and, with 90% probability hold a price between $85.98 and $98.83 at the end of this period.
Only positive signals in the chart today. Alnylam Pharmaceuticals holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $80.00 and $75.83. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Thursday August 15, 2019, which indicates further gains until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal.
Relative Strength Index (RSI)
RSImin/max Values: [ 25 - 75 ]
RSI14 is 57 and the stock is currently not being overbought or oversold
* Stockinvest.us uses dynamical calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behaviour.
Support & Resistance
Alnylam Pharmaceuticals finds support from accumulated volume at $80.50.
This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $2.04 (2.54%) between high and low. For the last week, the stock has had daily average volatility of 2.76%.
Our recommended stop-loss: $78.48 (-4.53%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from pivot bottom found 2 days ago.)
2.76 %Average volatility
Very Low Low Medium High Very High
Alnylam Pharmaceuticals holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months. We have upgraded our recommendation for this stock since last evaluation from a Buy Candidate to a Strong Buy Candidate.
|ALNY $82.20 ($1.51 1.87%)|
ALNY is up $1.51 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for ALNY based on the 1-3 month system that more than doubles the S&P 500.
This report is free today for StockInvest.us readers.
Click here – the ALNY analysis is free »
Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!